Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesalamine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Lymphoid 1

Conditions

Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

Rituximab 1168 Cyclophosphamide 1107 Vincristine 557 Doxorubicin 498 Etoposide 449 Prednisone 423 Cytarabine 404 fludarabine 398 Methotrexate 359 Dexamethasone 339 fludarabine phosphate 328 Lenalidomide 300 Filgrastim 296 Bendamustine Hydrochloride 232 Radiotherapy 230 venetoclax 217 ibrutinib 206 obinutuzumab 195 Melphalan 191 Peripheral Blood Stem Cell Transplantation 189 Granulocyte Colony-Stimulating Factor 174 Gemcitabine 169 Bortezomib 165 Busulfan 157 Whole-Body Irradiation 156 Mycophenolic Acid 144 Tacrolimus 124 Specimen Handling 121 Calcium Dobesilate 121 pegaspargase 120

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093663 2021-06-09

PACE

Takeda

Phase 3 Completed

107 enrolled 18 charts

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡